IOBCF (Ion Beam Applications) Receivables Turnover: 3.74 (As of Dec. 2025)


IOBCF Ion Beam Applications SA IOBCF
82 GF Score
Price $19.00
GF Value $17.98
Valuation Fairly Valued
! 10 Warning Signs
View Full Analysis

What is Ion Beam Applications Receivables Turnover?

Ion Beam Applications IOBCF +0.51% 82 Receivables Turnover is 3.74 as of Dec. 2025. GuruFocus rates IOBCF with a GF Score™ of 82/100 and a GF Value™ of $17.98 (Fairly Valued). The stock has 10 warning signs investors should review. Among 812 Medical Devices & Instruments companies, Ion Beam Applications ranks better than 72.17% on this metric.

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Ion Beam Applications's Revenue for the six months ended in Dec. 2025 was $369.1 Mil. Ion Beam Applications's average Accounts Receivable for the six months ended in Dec. 2025 was $98.8 Mil. Hence, Ion Beam Applications's Receivables Turnover for the six months ended in Dec. 2025 was 3.74.


Ion Beam Applications  (OTCPK:IOBCF) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Ion Beam Applications Receivables Turnover Related Terms


Ion Beam Applications Receivables Turnover Historical Data

* Premium members only.

The historical data trend for Ion Beam Applications's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ion Beam Applications Receivables Turnover Chart

Ion Beam Applications Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.34 3.75 4.32 5.15 7.33

Ion Beam Applications Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.96 1.96 2.85 4.14 3.74

IOBCF vs ABT, SYK, MDT: Receivables Turnover Comparison

For the Medical Devices subindustry, Ion Beam Applications's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ion Beam Applications Receivables Turnover vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ion Beam Applications's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Ion Beam Applications's Receivables Turnover falls into.


IOBCF
82GF Score
Ion Beam Applications SA IOBCF
Receivables Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ion Beam Applications Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Ion Beam Applications's Receivables Turnover for the fiscal year that ended in Dec. 2025 is calculated as

Receivables Turnover (A: Dec. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (A: Dec. 2025 ) / ((Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Dec. 2025 )) / count )
=726.2 / ((85.361 + 112.8) / 2 )
=726.2 / 99.0805
=7.33

Ion Beam Applications's Receivables Turnover for the quarter that ended in Dec. 2025 is calculated as

Receivables Turnover (Q: Dec. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Dec. 2025 ) / ((Accounts Receivable (Q: Jun. 2025 ) + Accounts Receivable (Q: Dec. 2025 )) / count )
=369.149 / ((84.702 + 112.8) / 2 )
=369.149 / 98.751
=3.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Receivables Turnover →
What does a Receivables Turnover of 3.74 mean?
Ion Beam Applications (IOBCF) has a Receivables Turnover of 3.74 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Ion Beam Applications and its competitors. According to the industry distribution chart, Ion Beam Applications ranks #226 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 27.8%.
Is Ion Beam Applications' Receivables Turnover too high?
Ion Beam Applications' current Receivables Turnover is 3.74. The Medical Devices & Instruments industry median Receivables Turnover is 5.57. Ion Beam Applications' value of 3.74 is 32.8% below this industry median. Based on the distribution chart, Ion Beam Applications ranks #226 out of 812 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Ion Beam Applications has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ion Beam Applications' Receivables Turnover compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ion Beam Applications ranks #226 out of 812 companies for Receivables Turnover. This puts Ion Beam Applications in the upper half of its industry. The industry median Receivables Turnover is 5.57. Ion Beam Applications' value of 3.74 is 32.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.57, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ion Beam Applications's current Receivables Turnover of 3.74 is 32.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Ion Beam Applications and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ion Beam Applications's current Receivables Turnover is 3.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ion Beam Applications stock overvalued right now?
Based on GuruFocus' analysis, Ion Beam Applications (IOBCF) is currently considered Fairly Valued. The stock's GF Value™ is $17.98, compared to a current price of $19.00 — trading 5.7% above its estimated fair value. The current Receivables Turnover is 3.74 and 32.8% below the Medical Devices & Instruments industry median of 5.57. Ion Beam Applications' overall GF Score™ is 82/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Ion Beam Applications (IOBCF), the current Receivables Turnover is 3.74 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ion Beam Applications (IOBCF) Overvalued in 2026?

Based on GuruFocus' analysis, Ion Beam Applications stock appears to be overvalued. The current stock price of $19.00 is trading 5.7% above its estimated GF Value™ of $17.98. GuruFocus considers Ion Beam Applications to be Fairly Valued.

Key valuation signals for IOBCF:

  • Receivables Turnover: 3.74
  • GF Value™: $17.98 vs. price of $19.00 (5.7% above fair value)
  • GF Score™: 82/100 with 10 warning signs
  • Industry Position: 32.8% below the Medical Devices & Instruments median (#226 of 812)

No single metric tells the full story. See the IOBCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ion Beam Applications Business Description

Address Chemin du Cyclotron, 3, Louvain-La-Neuve, BEL, B-1348
Ion Beam Applications SA develops and manufactures medical devices and software solutions. The firm operates in three segments: IBA Clinical, including Proton Therapy and Dosimetry; IBA Technologies; and IBA Corporate. Proton therapy and other accelerators contribute to the majority of sales. It offers solutions for precision cancer treatment through the use of proton beams, as well as cyclotrons used for the production of radioisotopes and industrial accelerators for sterilization and ionization. The dosimetry business sells measurement and quality assurance instruments for radiotherapy and medical imaging. The firm operates in three geographical areas: Belgium, the United States, China, Germany, and India.
82GF Score

Get the complete analysis for IOBCF

Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.00
Price
$17.98
GF Value